Skip to Main Content
Skip Nav Destination


Lanadelumab

Basics

Name

Lanadelumab

Pronunciation

(LAN a DEL ue mab)

Brand Names: US

  • Takhzyro

Therapeutic Category

  • Kallikrein Inhibitor
  • Monoclonal Antibody

Generic Availability (US)

No

Index Terms

  • Lanadelumab-flyo

Brand Names: International

  • (AE)United Arab Emirates: Takhzyro
  • (AR)Argentina: Takhzyro
  • (AT)Austria: Takhzyro
  • (AU)Australia: Takhzyro
  • (BE)Belgium: Takhzyro
  • (BG)Bulgaria: Takhzyro
  • (BR)Brazil: Takhzyro
  • (CH)Switzerland: Takhzyro
  • (CO)Colombia: Takhzyro
  • (CZ)Czech Republic: Takhzyro
  • (DE)Germany: Takhzyro
  • (EE)Estonia: Takhzyro
  • (ES)Spain: Takhzyro
  • (FI)Finland: Takhzyro
  • (FR)France: Takhzyro
  • (GB)United Kingdom: Takhzyro
  • (HK)Hong Kong: Takhzyro
  • (HU)Hungary: Takhzyro
  • (IE)Ireland: Takhzyro
  • (IT)Italy: Takhzyro
  • (JP)Japan: Takhzyro
  • (KW)Kuwait: Takhzyro
  • (LT)Lithuania: Takhzyro
  • (LU)Luxembourg: Takhzyro
  • (MX)Mexico: Takhzyro
  • (NL)Netherlands: Takhzyro
  • (NO)Norway: Takhzyro
  • (PL)Poland: Takhzyro
  • (PR)Puerto Rico: Takhzyro
  • (PT)Portugal: Takhzyro
  • (QA)Qatar: Takhzyro
  • (RO)Romania: Takhzyro
  • (SA)Saudi Arabia: Takhzyro
  • (SE)Sweden: Takhzyro
  • (SI)Slovenia: Takhzyro
  • (SK)Slovakia: Takhzyro
This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal